Dr. Claire Wagner, MD, MBA, is Head of Corporate Strategy and Market Access at the Bill & Melinda Gates Medical Research Institute where she supports the execution of the CEO’s vision and serves as a member of the executive leadership team. She leads the institute’s global access strategy and related partner engagement. Prior to joining the institute, Claire served in Kigali, Rwanda working for Rwanda’s Minister of Health, Dr. Agnes Binagwaho, and Harvard University Professor Dr. Paul Farmer advancing national health sector reforms. Claire later coordinated a global effort with the Dana-Farber Cancer Institute and the Union for International Cancer Control resulting in the 2015 expansion of the World Health Organization’s Model List of Essential Medicines for cancer. She has since consulted for pharmaceutical companies and non-profits regarding access to healthcare products and services worldwide. Claire is an Associate Scientist in Medicine in the Division of Global Health Equity at the Brigham and Women’s Hospital and is co-author of >40 scientific publications. She has an M.D. from Harvard Medical School and an M.B.A. from Harvard Business School where she was Commencement Class Day Speaker.